Reactions Weekly

, Volume 1178, Issue 1, pp 5–5 | Cite as

Earlier epoetin labelling changes expanded by US FDA

Media release
  • 8 Downloads

Keywords

Chronic Renal Failure Zidovudine Darbepoetin Alfa Boxed Warning Chronic Renal Failure Patient 

REFERENCE

  1. 1.
    FDA.FDA Strengthens Boxed Warnings, Approves Other Safety Labeling Changes for Erythropoiesis-Stimulating Agents (ESAs). Media Release: 8 Nov 2007. Available from: URL: http://www.fda.gov

Copyright information

© Adis International limited or Adis Data Information BV 2007

Personalised recommendations